Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that emergency or urgently needed care services while traveling outside the United States or its 
territories during a temporary absence of less than six months. Outpatient copay is waived if member is 
admitted to hospital within 72 hours for the same condition. The contract also says This coverage is worldwide 
and is limited to what is allowed under the Medicare fee schedule for the services performed/received in the 
United States. You can find this information on page 43 of the Plan's 2021 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that if a laboratory assays two or more genes in a patient in parallel, then those two or more 
genes will be considered part of the same panel. A panel constitutes a single procedural service, so one code 
must be submitted for the panel. This rule can be found in Medicare National Coverage Determination: Next 
Generation Sequencing (NGS) 90.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will not pay for dental services. Dental services are items and services involving 
the care, treatment, filling, removal or replacement of teeth or structures directly supporting the teeth. Medicare 
defines "structures directly supporting the teeth" as the periodontium, which includes the gingivae, 
dentogingival junction, periodontal membrane, cementum of the teeth, and alveolar process. You can find this 
rule in the Social Security Act, Section 1862(a)(12) and in the Centers for Medicare and Medicaid Services, 
Internet Only Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 150. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan covers certain dental services as a supplemental (extra) benefit. This benefit includes one 
panoramic x-ray every three plan years. You can find this information on page 4-81 of the Plans 2021 
Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare Part B generally does not pay for drugs that are usually self-administered by the 
patients who take them. Examples of self-administered drugs are drugs in pill form and those used for self-
injection. The only exceptions are: 
 
1. blood-clotting factors;  
2. drugs used in immunosuppressive therapy; 
3. erythropoietin for dialysis patients;  
4. osteoporosis drugs for certain homebound patients; 
5. certain oral cancer drugs;  
6. oral anti-emetics used in certain situations;  
7. drugs treated as supplies during an outpatient hospital procedure; and  
8. drugs required for the effective use of durable medical equipment. 
You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 
100-02, Medicare Benefit Policy Manual, Chapter 15, Sections 50, 50.2, 50.5, and 110.3. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract also says that covered drugs include drugs that usually arent self-administered by the patient and are 
injected or infused while you are getting physician, hospital 
outpatient, or ambulatory surgical center services. You can find this information on page 84 of the Plan's 2021 
Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that definitive drug testing (UDT) is reasonable and necessary for the following circumstances: 
 
-Identify a specific substance or metabolite that is inadequately detected by a presumptive UDT; 
-Definitively identify specific drugs in a large family of drugs; 
-Identify a specific substance or metabolite that is not detected by presumptive UDT such as fentanyl, 
meperidine, synthetic cannabinoids and other synthetic/analog drugs; 
-Identify drugs when a definitive concentration of a drug is needed to guide management (e.g., discontinuation 
of THC use according to a treatment plan); 
-Identify a negative, or confirm a positive, presumptive UDT result that is inconsistent with a patients self-
report, presentation, medical history, or current prescribed pain medication plan; 
-Rule out an error as the cause of a presumptive UDT result; 
-Identify non-prescribed medication or illicit use for ongoing safe prescribing of controlled substances; and 
-Use in a differential assessment of medication efficacy, side effects, or drug-drug interactions. 
 
You can find this rule in the Local Coverage Determination (LCD) - Lab: Controlled Substance Monitoring 
and Drugs of Abuse Testing (L36707) - Effective April 8, 2021. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that plans may require enrollees to obtain authorization before receiving services. You can find 
this rule at 42 CFR Section 422.112(a) and in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-16, Medicare Managed Care Manual, Chapter 1, Section 20.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that prior authorization rules may apply to outpatient diagnostic tests. You can find this 
information on page 87 of the Plan's 2021 Evidence of Coverage. In addition, the Plan's contract states that 
prior authorization is required for all genetic testing not related to pregnancy.  You can find this information on 
page 1 of the Plan's Prior Authorization List.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
To be considered reasonable and necessary, the services must meet Medicare guidelines. The guidelines for 
coverage of outpatient therapies have basic requirements in common. 
 
In the case of rehabilitative therapy, the patients condition has the potential to improve or is improving in 
response to therapy, maximum improvement is yet to be attained; and there is an expectation that the 
anticipated improvement is attainable in a reasonable and generally predictable period of time. Refer to Centers 
for Medicare and Medicaid Services (CMS) Publication 100-02, Medicare Benefit Policy Manual, chapter 15, 
section 220.2(C). 
 
If the goal of the plan of care is to improve functioning, the documentation must establish that the patient needs 
the unique skills of a therapist to improve functioning. If the goal of the plan of care is to maintain, prevent or 
slow further deterioration of functional status function or prevent deterioration, the documentation must 
establish that the patient needs the unique skills of a therapist to maintain, prevent or slow further deterioration 
of functional status. 
 
The services that are provided must meet the description of skilled therapy as defined in this article. You can 
find this information in the Centers for Medicare and Medicaid Services, Local Coverage Determination 
(LCD): Outpatient Physical and Occupational Therapy Services (L33631). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that repeat thermal facet joint radiofrequency ablation (RFA) at the same anatomic site is 
considered medically reasonable and necessary provided the patient had a minimum of consistent 50% 
improvement in pain for at least six (6) months or at least 50% consistent improvement in the ability to perform 
previously painful movements and activities of daily living (ADLs) as compared to baseline measurement 
using the same scale. For each covered spinal region no more than two (2) radiofrequency sessions will be 
reimbursed per rolling 12 months. You can find these rules in Local Coverage Determination (LCD) Facet 
Joint Interventions for Pain Management (L38803). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that providers/suppliers must report services correctly. Procedures should be reported with the 
Current Procedural Terminology (CPT) code that describes the services performed. You can find this rule in 
the Centers for Medicare and Medicaid Services, Medicare National Correct Coding Initiative Policy Manual 
for Medicare Services, Chapter I(A). 
 
The rules say that effective January 1, 2017, providers and suppliers are required to report the JW modifier on 
Part B drug claims for discarded drugs and biologicals. Also, providers and suppliers must document the 
amount of discarded drugs or biologicals in Medicare beneficiaries medical records. You can find this rule in 
the Centers for Medicare and Medicaid Services (CMS), Internet-Only Manual, Publication 100-04, Medicare 
Claims Processing Manual  Chapter 17, Section 40 and the MLN Matters MM9603. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that no payment may be made for the implantation of dorsal column or depth brain stimulators 
or services and supplies related to such implantation, unless all of the conditions listed below have been met: 
- The implantation of the stimulator is used only as a late resort (if not a last resort) for patients with 
chronic intractable pain; 
- With respect to item a, other treatment modalities (pharmacological, surgical, physical, or psychological 
therapies) have been tried and did not prove satisfactory, or are judged to be unsuitable or 
contraindicated for the given patient; 
- Patients have undergone careful screening, evaluation and diagnosis by a multidisciplinary team prior to 
implantation. (Such screening must include psychological, as well as physical evaluation); 
- All the facilities, equipment, and professional and support personnel required for the proper diagnosis, 
treatment training, and follow up of the patient (including that required to satisfy item c) must be 
available; and 
- Demonstration of pain relief with a temporarily implanted electrode precedes permanent implantation. 
 
You can find these rules in National Coverage Determination (NCD) Electrical Nerve Stimulators (160.7). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay a $40 copayment for physical and occupational therapy provided at an  
in-network outpatient hospital. You can find this information on pages 81-82 of the Plan's 2021 Evidence of 
Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that parenteral nutrition is the provision of nutritional requirements intravenously and is covered 
for beneficiaries who qualify under the Prosthetic Device Benefit defined in the Medicare Benefit Policy 
Manual (CMS Pub. 100-02), Chapter 15, Section 120. 
 
When nutritional support other than the oral route is necessary, enteral nutrition (EN) is usually initially 
preferable to parenteral nutrition for the following reasons: (1) In a fluid restricted beneficiary, EN permits 
delivery of all necessary nutrients in a more concentrated volume than parenteral nutrition; (2) EN allows for 
safer home delivery of nutrients; and (3) EN lowers the risk of Central Line-Associated Bloodstream Infections 
(CLABSI). 
 
For parenteral nutrition to be considered reasonable and necessary, the treating practitioner must document that 
enteral nutrition has been considered and ruled out, tried and been found ineffective, or that EN exacerbates 
gastrointestinal tract dysfunction. The beneficiary must have (a) a condition involving the small intestine and/or 
its exocrine glands which significantly impairs the absorption of nutrients or (b) disease of the stomach and/or 
intestine which is a motility disorder and impairs the ability of nutrients to be transported through and absorbed 
by the gastrointestinal (GI) system. The beneficiary must have a permanent impairment. Please refer to the 
LCD-related Policy Article for further guidance regarding the test of permanence.   
 
The treating practitioner is required to evaluate the beneficiary within 30 days prior to initiation of parenteral 
nutrition. If the treating practitioner does not see the beneficiary within this timeframe, they must document the 
reason why and describe what other monitoring methods were used to evaluate the beneficiary's parenteral 
nutrition needs. There must be documentation in the medical record supporting the clinical diagnosis. 
 
You can find this information in the Local Coverage Determination (LCD) L38953. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay a 20% coinsurance for Medicare-covered Part B chemotherapy drugs and 
other Part B drugs. You can find this information on page 52 of the Plan's 2021 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that currently covered indications include using MRA for specific conditions to evaluate flow in 
internal carotid vessels of the head and neck, peripheral arteries of lower extremities, abdomen and pelvis, and 
the chest. Coverage is limited to MRA units that have received FDA premarket approval, and such units must 
be operated within the parameters specified by the approval. In addition, the services must be reasonable and 
necessary for the diagnosis or treatment of the specific patient involved. 
 
Studies have proven that MRA is effective for evaluating flow in internal carotid vessels of the head and neck. 
However, not all potential applications of MRA have been shown to be reasonable and necessary. All of the 
following criteria must apply in order for Medicare to provide coverage for MRA of the head and neck:  
   MRA is used to evaluate the carotid arteries, the circle of Willis, the anterior, middle or posterior cerebral 
arteries, the vertebral or basilar arteries or the venous sinuses;  
   MRA is performed on patients with conditions of the head and neck for which surgery is anticipated and 
may be found to be appropriate based on the MRA. These conditions include, but are not limited to, tumor, 
aneurysms, vascular malformations, vascular occlusion or thrombosis. Within this broad category of disorders, 
medical necessity is the underlying determinant of the need for an MRA in specific diseases. The medical 
records should clearly justify and demonstrate the existence of medical necessity; and  
   MRA and CA are not expected to be performed on the same patient for diagnostic purposes prior to the 
application of anticipated therapy. Only one of these tests will be covered routinely unless the physician can 
demonstrate the medical need to perform both tests.  
 
You can find this information in the Centers for Medicare and Medicaid Service, Internet-Only Manual, 
Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Section 
220.2(B)(2) 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare Advantage (MA) plans may specify brands and manufacturers as preferred and 
charge lower cost-sharing for the preferred brands or may limit the durable medical equipment (DME) to only 
those preferred brands and manufacturers, as long as the following conditions are met (42 CFR 422.100(l)): 
 
 The MA plan provides all categories of DME covered under original Medicare Part B; 
 The MA plan ensures that enrollees have access to all medically necessary (including non-preferred) DME 
products or brands; 
 The MA plans contracted suppliers provide access to all preferred DME brands; 
 During an enrollees first year of enrollment in an MA plan, if the enrollee requests, the plan will provide a 
90-day transition period (commencing with the initial time of enrollment) during which the plan provides (and 
repairs, as applicable) non-preferred DME brands furnished in the previous year; 
 Although the MA plan may add brands to its preferred formulary during the year, it may not remove any 
brands mid-year; 
 The MA plan treats denials of non-preferred DME products or brands as organization determinations; 
 The MA plan discloses DME coverage limitations and appeal rights in the case of a denial of a non-preferred 
DME product or brand with the Evidence of Coverage (EOC) and Annual Notice of Changes (ANOC) and on 
its website; and 
 The MA plan provides full coverage, without limitation on brand and manufacturer, to DME categories or 
subcategories annually determined by Medicare to require full coverage. 
 
You can find this information in the Centers for Medicare and Medicaid Services (CMS), Internet-Only 
Manual, Publication 100-16, Medicare Managed Care Manual, Chapter 4. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract also says that diabetic testing supplies obtained through the pharmacy are limited to specified brands. 
Prior approval will be required for any other brands of meters and test strips. You can find this information on 
pages 66 to 67 of the Plan's 2022 Evidence of Coverage (EOC).